GSK Investigational Site

Jeffersonville, Indiana 47130

0 studies enrolling now · 9 studies all time

What they study most

Anaemia, Aspergillosis, Allergic Bronchopulmonary, Erectile Dysfunction, Incontinence, Urinary and Urinary Bladder, Overactive, Irritable Bowel Syndrome (IBS), Irritable Colon, Neoplasms, Prostate, Overactive Bladder, Prostatic Hyperplasia

Studies at this site

• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
• A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy — Completed
• A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed